Article
The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies…
bioRxiv: the preprint server for biology · 2021 · Sonia Ndeupen, author Zhen Qin, author Sonya Jacobsen, author Henri Estanbouli, author Aurélie Bouteau, author Botond Z. Igyártó, author
Key facts
| Title | The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory |
|---|---|
| First author | Sonia Ndeupen, author Zhen Qin, author Sonya Jacobsen, author Henri Estanbouli, author Aurélie Bouteau, author Botond Z. Igyártó, author |
| Journal | bioRxiv : the preprint server for biology |
| Published | Mar 7, 2021 |
| DOI | 10.1101/2021.03.04.430128 |
| Product codes mentioned | JJH, MVU, OHQ |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1